Survival from digestive cancer in emerging countries in Asia and Africa

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 6, 2012, Pages 605-612

  Lambert, René ^a   Saito, Hiroshi ^b   Lucas, Eric ^a   Sankaranarayanan, Rengaswamy ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

cancer; colon; developing countries; esophagus; incidence liver; mortality; rectum; stomach; survival

Indexed keywords

AFRICA; ASIA; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CENTRAL AMERICA; CHINA; CLINICAL STUDY; COLON CANCER; DEVELOPING COUNTRY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; GASTRITIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DISTRIBUTION; HELICOBACTER INFECTION; HUMAN; INDIA; JAPAN; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LIVER CANCER; NUTRITION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; SINGAPORE; SOUTH AND CENTRAL AMERICA; STOMACH ATROPHY; STOMACH CANCER;

AFRICA; ASIA; DEVELOPING COUNTRIES; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; INCIDENCE; MORTALITY;

EID: 84861196895     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328351e39d     Document Type: Review

References (31)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Maxwell Parkin D, et al. GLOBOCAN 2008 Cancer incidence and mortality worldwide: IARC Cancer Base No. 10. IARC Lyon; 2010. Available at http://globocan. iarc.fr [Accessed 9 January 2012].
2. Ries L A G, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J. SEER survival monograph: cancer survival among adults: US SEER Program, 1988-2001, Patient and tumor characteristics. National Cancer Institute, SEER Program NIH Pub. No. 07-6215 Bethesda, MD 2007.
3. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-991.
4. Sankaranarayanan R, Black RJ, Parkin DM. Cancer survival in developing countries. IARC Scientific Publications No. 145. Lyon: IARC; 1998.
5. Sankaranarayanan R, Swaminathan R. Cancer survival in Africa, Asia, the Caribbean and Central America. IARC Scientific Publications No. 162. Lyon: IARC; 2011.
6. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, et al. Cancer survival in Africa, Asia, and Central America: a populationbased study. Lancet Oncol 2010;11:165-173.
7. Sankaranarayanan R, Swaminathan R, Black RJ. Global variations in cancer survival. Study group on cancer survival in developing countries. Cancer 1996;78:2461-2464.
8. Swaminathan R, Rama R, Shanta V. Lack of active follow-up of cancer patients in Chennai, India: implications for population-based survival estimates. Bull World Health Organ 2008;86:509-515.
9. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute. 1975-2008. Available at http://seer.cancer.gov/csr/1975-2008/[Accessed 9 January 2012].
10. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 2002;162:1985-1993.
11. Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14(Suppl 5):128-149.
12. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784-796.
13. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-783.
14. De Angelis R, Francisci S, Baili P, Marchesi F, Roazzi P, Belot A, et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009;45:909-930.
15. Berrino F, Capocaccia R, estève J, Gatta G, Hakulinen T, Micheli A, et al. Survival of cancer patients in Europe: the EUROCARE-2 study. IARC Scientific Publications No. 151. Lyon: IARC; 1999. pp. 1-572.
16. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 2003;14(Suppl 5):61-118.
17. Brenner H, Francisci S, de Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, et al. Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer 2009;45:1028-1041.
18. Tsukuma H, Ajiki W, Ioka A, Oshima A. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol 2006;36:602-607.
19. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T. Research Group of Population-Based Cancer Registries of Japan. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 2011;41:40-51.
20. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730-756.
21. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanu M, et al. Cancer incidence in five continents. IARC Scientific Publications. Lyon: IARC; 2007.
22. Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J. Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer 2000;82:1863-1866.
23. Ciccolallo L, Capocaccia R, Coleman MP, Berrino F, Coebergh JW, Damhuis RA, et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 2005;54:268-273.
24. Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 2007;121:395-400.
25. Foundation for Promotion of Cancer Research (Tokyo). Cancer Statistics in Japan 2005. The Editorial Board of the Cancer Statistics in Japan. Tokyo: Foundation for Promotion of Cancer Research; 2005.
26. Riboli E, Lambert R, eds. Nutrition and lifestyle: opportunities for cancer prevention. IARC Scientific publication 156, IARC Press, Lyon, 2002.
27. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 2011;16:415-419.
28. Hamashima C, Sobue T, Muramatsu Y, Saito H, Moriyama N, Kakizoe T. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program. Jpn J Clin Oncol 2006;36:301-308.
29. Heresbach D, Manfredi S, D'halluin PN, Bretagne JF, Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 2006;18:427-433.
30. Lambert R, Sauvaget C, Sankaranarayanan R. Mass screening for colorectal cancer is not justified in most developing countries. Int J Cancer 2009;125:253-256.
31. WHO Global Infobase. Proportional mortality. Available at https://apps.who.int/infobase/Mortality.aspxhttps://apps.who.int/infobase/ Mortality.aspx [Accessed 9 January 2012].